Improving Quality of Care in the Management
|

Harold Alan Pincus, MD
Module 1: Gaps in the quality of care in depression
Module 2: Barriers and strategies for evidence-based quality improvement models for depression
Module 3: Applying evidence to practice
Module 4: Quality initiatives on the horizon
Introduction
In the following video webcast, Dr. Harold Alan Pincus, Vice Chair for Strategic Initiatives, Department of Psychiatry, College of Physicians and Surgeons, Columbia University, Director of Quality and Outcomes Research, New York-Presbyterian Hospital, provides an overview of the current gaps in the quality of care for depression and the basis for those gaps. He further builds the case for applying evidence-based practices in providing quality care for depression in the primary care setting, and reviews current and future quality initiatives impacting depression care.
Information on CME credit
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Medical Association designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Nonphysicians may receive a certificate of participation for completing this activity.
Instructions for CME credit
This online enduring material is presented as a video webcast with attendant slide presentation. To receive credit, please view all of the presentations of this CME activity and evaluate the content presented. Complete both the pre- and post-test and activity evaluation.
The estimated time to complete this activity, including pre-test, review of the materials, and self-assessment and evaluation is 1.0 hour.
Principal Faculty
Wayne Katon, MD, Planning Committee Chair
Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Health Services and Psychiatric Epidemiology
University of Washington School of Medicine
Seattle, WA
Michael S. Klinkman, MD, Planning Committee
Associate Professor, Department of Medicine
Associate Professor, Department of Psychiatry
Department of Family Medicine
Director, Primary Care Programs
University of Michigan Depression Center
Ann Arbor, MI
Kurt Kroenke, MD, Planning Committee
Professor of Medicine
Indiana University School of Medicine
Research Scientist, Regenstrief Institute, Inc.
Indianapolis, IN
Harold Alan Pincus, MD, Author and Presenter
Vice Chair for Strategic Initiatives
Department of Psychiatry
College of Physicians and Surgeons
Columbia University
Director of Quality and Outcomes Research
New York-Presbyterian Hospital
John Williams, MD, Planning Committee, Content Reviewer
Associate Professor of Medicine and Psychiatry
General Medicine
Duke University School of Medicine
Durham, NC
R. Mark Evans, PhD, Planning Committee
Director, Healthcare Education Products and Standards
American Medical Association
Chicago, IL
Kristi Eidsvoog, PhD, Planning Committee
Content Manager
MedEd Architects, LLC
Chicago, IL
Patti Fitzgerald
Manager, Product Development, Healthcare Education Products and Standards
American Medical Association
Chicago, IL
Disclosure Policy
In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty and planning committee members disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being presented. We therefore obtain a completed disclosure and attestation form to inform the participant of any pertinent relationships disclosed, provided here.
These materials have been peer-reviewed to ensure the continued scientific accuracy and medical relevance of information presented and its independence from commercial bias. The AMA has control over all final content.
Dr. Katon: Advisory Board, Lilly, Wyeth; Speakers Bureau, Pfizer, Forest, GlaxoSmithKline
Dr. Klinkman: Advisory Board, Wyeth; Research Grant, Lilly; Independent Contractor, GE/Healthology
Dr. Kroenke: Research Grant, Lilly, Pfizer, Wyeth; Consultant, Lilly, Pfizer, Wyeth
Dr. Pincus: Consultant, Bristol Myers Squibb
Dr. Williams: Nothing relevant to disclose
Dr. Evans: Nothing relevant to disclose
Dr. Eidsvoog: Nothing relevant to disclose
Ms. Fitzgerald: Nothing relevant to disclose
Acknowledgement of Support
This CME publication was supported through an independent educational grant from Eli Lilly & Company and produced in accordance with the AMA Standards for Industry-Supported Multimedia Continuing Medical Education and Other Communications.
Intended Audience
This continuing medical education program is intended for primary care physicians and other healthcare professionals who manage patients with depressive disorders.
Educational Objectives
After completing this activity, participants should be better able to:
- Describe the current gaps in the quality of care for depression
- Recognize barriers to achieving quality depression care
- Describe evidence-based models for providing quality depression care
- Identify strategies for overcoming barriers and implementing quality of care
- Identify important policy initiatives relevant to depression care
Term of approval
Original Release Date- May 2008
Date of the Most Recent Review- May 2009
Expiration Date- December 2010



